IRBESARTAN
- Product NDC
- 50090-3244
- 11-digit product format
- 500903244
- Labeler code
- 50090
- Product ID
- 50090-3244_32265c04-5b29-40e1-9cc7-218ea79b393c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- IRBESARTAN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA203534
- Marketing category
- ANDA
- Marketing start
- 2015-02-24
- Marketing end
- 0000-00-00
- Substance
- IRBESARTAN
- Active strength
- 150 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-3244-0 | 50090324400 | 30 TABLET in 1 BOTTLE (50090-3244-0) | 30 tablet | 2017-11-03 | 0000-00-00 | No | No | Current |
| 50090-3244-1 | 50090324401 | 90 TABLET in 1 BOTTLE (50090-3244-1) | 90 tablet | 2018-05-09 | 0000-00-00 | No | No | Current |